GSK3B and cardiac hypertrophy: In cardiac hypertrophy, the overexpression of PPARα in cardiac tissue can mediate the p53/GSK3β signaling pathway to significantly improve myocardial energy deficiency and cardiac function, which also supports the important role of PPARα in the pathological process of cardiac hypertrophy (Rana et al., 2019).